Warning letter
Ribbon SRL [ARCHIVED]: warning letter of May 27, 2010
FDA warning letter 112568 · Center for Drug Evaluation and Research
Key facts
| Reference number | 112568 |
|---|---|
| Company | Ribbon SRL [ARCHIVED] |
| Subject | CGMP Regulation for Finished Pharmaceuticals/Adulterated |
| Issue date | May 27, 2010 |
| Posted date | May 27, 2010 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.67(a), 211.42(c)(10), 211.113(b) |
| Inspection city | Villadose |
| Inspection start date | Dec 8, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: